169 related articles for article (PubMed ID: 35731924)
1. Structural Analysis and Development of Notum Fragment Screening Hits.
Zhao Y; Mahy W; Willis NJ; Woodward HL; Steadman D; Bayle ED; Atkinson BN; Sipthorp J; Vecchia L; Ruza RR; Harlos K; Jeganathan F; Constantinou S; Costa A; Kjær S; Bictash M; Salinas PC; Whiting P; Vincent JP; Fish PV; Jones EY
ACS Chem Neurosci; 2022 Jul; 13(13):2060-2077. PubMed ID: 35731924
[TBL] [Abstract][Full Text] [Related]
2. Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment Hit.
Willis NJ; Mahy W; Sipthorp J; Zhao Y; Woodward HL; Atkinson BN; Bayle ED; Svensson F; Frew S; Jeganathan F; Monaghan A; Benvegnù S; Jolly S; Vecchia L; Ruza RR; Kjær S; Howell S; Snijders AP; Bictash M; Salinas PC; Vincent JP; Jones EY; Whiting P; Fish PV
J Med Chem; 2022 May; 65(10):7212-7230. PubMed ID: 35536179
[TBL] [Abstract][Full Text] [Related]
3. Structural characterization of melatonin as an inhibitor of the Wnt deacylase Notum.
Zhao Y; Ren J; Hillier J; Jones M; Lu W; Jones EY
J Pineal Res; 2020 Mar; 68(2):e12630. PubMed ID: 31876313
[TBL] [Abstract][Full Text] [Related]
4. Discovery of 2-phenoxyacetamides as inhibitors of the Wnt-depalmitoleating enzyme NOTUM from an X-ray fragment screen.
Atkinson BN; Steadman D; Zhao Y; Sipthorp J; Vecchia L; Ruza RR; Jeganathan F; Lines G; Frew S; Monaghan A; Kjær S; Bictash M; Jones EY; Fish PV
Medchemcomm; 2019 Aug; 10(8):1361-1369. PubMed ID: 31534655
[TBL] [Abstract][Full Text] [Related]
5. 5-Phenyl-1,3,4-oxadiazol-2(3
Mahy W; Willis NJ; Zhao Y; Woodward HL; Svensson F; Sipthorp J; Vecchia L; Ruza RR; Hillier J; Kjær S; Frew S; Monaghan A; Bictash M; Salinas PC; Whiting P; Vincent JP; Jones EY; Fish PV
J Med Chem; 2020 Nov; 63(21):12942-12956. PubMed ID: 33124429
[TBL] [Abstract][Full Text] [Related]
6. Screening of a Custom-Designed Acid Fragment Library Identifies 1-Phenylpyrroles and 1-Phenylpyrrolidines as Inhibitors of Notum Carboxylesterase Activity.
Mahy W; Patel M; Steadman D; Woodward HL; Atkinson BN; Svensson F; Willis NJ; Flint A; Papatheodorou D; Zhao Y; Vecchia L; Ruza RR; Hillier J; Frew S; Monaghan A; Costa A; Bictash M; Walter MW; Jones EY; Fish PV
J Med Chem; 2020 Sep; 63(17):9464-9483. PubMed ID: 32787107
[TBL] [Abstract][Full Text] [Related]
7. Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity.
Steadman D; Atkinson BN; Zhao Y; Willis NJ; Frew S; Monaghan A; Patel C; Armstrong E; Costelloe K; Magno L; Bictash M; Jones EY; Fish PV; Svensson F
J Med Chem; 2022 Jan; 65(1):562-578. PubMed ID: 34939789
[TBL] [Abstract][Full Text] [Related]
8. Structural Insights into Notum Covalent Inhibition.
Zhao Y; Svensson F; Steadman D; Frew S; Monaghan A; Bictash M; Moreira T; Chalk R; Lu W; Fish PV; Jones EY
J Med Chem; 2021 Aug; 64(15):11354-11363. PubMed ID: 34292747
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Dengue virus helicase and methyltransferase as targets for fragment-based drug discovery.
Coutard B; Decroly E; Li C; Sharff A; Lescar J; Bricogne G; Barral K
Antiviral Res; 2014 Jun; 106():61-70. PubMed ID: 24704437
[TBL] [Abstract][Full Text] [Related]
10. Carboxylesterase Notum Is a Druggable Target to Modulate Wnt Signaling.
Bayle ED; Svensson F; Atkinson BN; Steadman D; Willis NJ; Woodward HL; Whiting P; Vincent JP; Fish PV
J Med Chem; 2021 Apr; 64(8):4289-4311. PubMed ID: 33783220
[TBL] [Abstract][Full Text] [Related]
11. A crystallographic fragment screen identifies cinnamic acid derivatives as starting points for potent Pim-1 inhibitors.
Schulz MN; Fanghänel J; Schäfer M; Badock V; Briem H; Boemer U; Nguyen D; Husemann M; Hillig RC
Acta Crystallogr D Biol Crystallogr; 2011 Mar; 67(Pt 3):156-66. PubMed ID: 21358046
[TBL] [Abstract][Full Text] [Related]
12. Small-molecule inhibitors of carboxylesterase Notum.
Zhao Y; Jolly S; Benvegnu S; Jones EY; Fish PV
Future Med Chem; 2021 Jun; 13(11):1001-1015. PubMed ID: 33882714
[TBL] [Abstract][Full Text] [Related]
13. Caffeine inhibits Notum activity by binding at the catalytic pocket.
Zhao Y; Ren J; Hillier J; Lu W; Jones EY
Commun Biol; 2020 Oct; 3(1):555. PubMed ID: 33033363
[TBL] [Abstract][Full Text] [Related]
14. Designed switch from covalent to non-covalent inhibitors of carboxylesterase Notum activity.
Atkinson BN; Willis NJ; Zhao Y; Patel C; Frew S; Costelloe K; Magno L; Svensson F; Jones EY; Fish PV
Eur J Med Chem; 2023 May; 251():115132. PubMed ID: 36934521
[TBL] [Abstract][Full Text] [Related]
15. Frag4Lead: growing crystallographic fragment hits by catalog using fragment-guided template docking.
Metz A; Wollenhaupt J; Glöckner S; Messini N; Huber S; Barthel T; Merabet A; Gerber HD; Heine A; Klebe G; Weiss MS
Acta Crystallogr D Struct Biol; 2021 Sep; 77(Pt 9):1168-1182. PubMed ID: 34473087
[TBL] [Abstract][Full Text] [Related]
16. Identification of N-ethylmethylamine as a novel scaffold for inhibitors of soluble epoxide hydrolase by crystallographic fragment screening.
Amano Y; Tanabe E; Yamaguchi T
Bioorg Med Chem; 2015 May; 23(10):2310-7. PubMed ID: 25862210
[TBL] [Abstract][Full Text] [Related]
17. Novel approach of fragment-based lead discovery applied to renin inhibitors.
Tawada M; Suzuki S; Imaeda Y; Oki H; Snell G; Behnke CA; Kondo M; Tarui N; Tanaka T; Kuroita T; Tomimoto M
Bioorg Med Chem; 2016 Nov; 24(22):6066-6074. PubMed ID: 27720325
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel Cyclophilin D inhibitors starting from three dimensional fragments with millimolar potencies.
Grädler U; Schwarz D; Blaesse M; Leuthner B; Johnson TL; Bernard F; Jiang X; Marx A; Gilardone M; Lemoine H; Roche D; Jorand-Lebrun C
Bioorg Med Chem Lett; 2019 Dec; 29(23):126717. PubMed ID: 31635932
[TBL] [Abstract][Full Text] [Related]
19. Lead generation and examples opinion regarding how to follow up hits.
Orita M; Ohno K; Warizaya M; Amano Y; Niimi T
Methods Enzymol; 2011; 493():383-419. PubMed ID: 21371599
[TBL] [Abstract][Full Text] [Related]
20. Fragment-based screening by X-ray crystallography, MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitors.
Drinkwater N; Vu H; Lovell KM; Criscione KR; Collins BM; Prisinzano TE; Poulsen SA; McLeish MJ; Grunewald GL; Martin JL
Biochem J; 2010 Oct; 431(1):51-61. PubMed ID: 20642456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]